Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204)

Medicine

Volumn 76, Issue 5, 1997, Pages 369-380

  Bell, William R ^a,d   Chulay, Jeffrey D ^b   Feinberg, Judith E ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CD4 ANTIGEN; CLOFAZIMINE; COTRIMOXAZOLE; CREATININE; ETHAMBUTOL; FLUCONAZOLE; PREDNISONE; VALACICLOVIR;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DOUBLE BLIND PROCEDURE; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY BIOPSY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ACYCLOVIR; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; DOUBLE-BLIND METHOD; HEMOLYTIC-UREMIC SYNDROME; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PRODRUGS; PROSPECTIVE STUDIES; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RISK FACTORS; VALINE;

EID: 0030773132     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-199709000-00004     Document Type: Article

References (76)

1. Agresti A. Analysis of ordinal categorical data. New York: John Wiley, p 15-17, 1984.
2. Amarosi EL, Ultmann JE. Thrombotic thrombocytopenic purpura: Report of 16 cases and review of literature. Medicine (Baltimore) 45: 139-59, 1966.
3. Bachmeyer C, Blanche P, Sereni D, Salmon D, Grateau G, Dreyfus F, Sicard D. Thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome in HTV-infected patients. AIDS 9: 532-33, 1995.
4. Badesha PS, Saklayen MG. Hemolytic uremic syndrome as a presenting form of HTV infection. Nephron 72: 472-75, 1996.
5. Balfour HH Jr, Chace BA, Stapleton JT, Simmons RL, Fryd DS. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med 320: 1381-87, 1989.
6. Becker BN, Fall P, Hall C, Milam D, Leonard J, Glick A, Schulman G. Rapidly progressive acute renal failure due to acyclovir: Case report and review of the literature. Am J Kidney Dis 22: 611-15, 1993.
7. Bell MD, Barnhart JS Jr, Martin JM. Thrombotic thrombocytopenic purpura causing sudden, unexpected death - a series of eight patients. J Forensic Sci 35: 601-13, 1990.
8. Bell WR. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome relapse: Frequency, pathogenesis and meaning. Semin Hematol 34: 134-39, 1997.
9. Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 325: 398-403, 1991.
10. Beris P, Dunand V, Isoz C, Reynard C. Association of thrombotic thrombocytopenic purpura and human immunodeficiency virus infection. Nouv Rev Fr Hematol 32: 277-80, 1990.
11. Besalduch J, Altes J, Morey M, Villalonga C. Thrombotic thrombocytopenic purpura and infection by the human immunodeficiency virus. Med Clin (Barc) 92: 795-96, 1989.
12. Blanche P, Bachmeyer C, Sereni D, Salmon D, Boissonnas A, Dreyfus F, Sicard D. Hemolytic uremic syndrome in patients with HTV infection. In: 10th International Conference on AIDS/International Conference on STD, 7-12 August 1994, Yokohama, 1994.
13. Boccia RV, Gelmann EP, Baker CC, Marti G, Longo DL. A hemolytic-uremic syndrome with the acquired immunodeficiency syndrome. Ann Intern Med 101: 716-17, 1984.
14. Botti AC, Hyde P, DiPillo F. Thrombotic thrombocytopenic purpura in a patient who subsequently developed the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 109: 242-43, 1988.
15. Boyce TG, Swerdlow DL, Griffin PM. Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 333: 364-68, 1995.
16. Bullorsky EO, Shanley C, Napoli J, Stemmelin G, Emery J, Lajous JR. Thrombotic thrombocytopenic purpura and human acquired immunodeficiency virus seropositivity. Medicina (B Aires) 51: 241-43, 1991.
17. Campayo Ibanez A, Perello Roso A, Lacruz Rodrigo J, Valls Ferrer JM, de la Rubia Comos J, Lopez Chuelia F. Thrombotic thrombopenic purpura and HIV infection. Apropos of a case. An Med Interna 11: 493-95, 1994.
18. Cervero Marti A, Martin J, Perez-Paya A, Sanchis J, Canelles P, Garcia-Marco J, Sanchez M. Hemolytic-uremic syndrome associated with pancreatitis in an HIV-positive patient. Ann Hematol 65: 236-37, 1992.
19. Charasse C, Michelet C, Le Tulzo Y, Liegaux JM, Camus C, Thomas R, Cartier F, Ramee MP. Thrombotic thrombocytopenic purpura with the acquired immunodeficiency syndrome: A pathologically documented case report. Am J Kidney Dis 17: 80-82, 1991.
20. Chu QD, Medeiros LJ, Fisher AE, Chaquette RF, Crowley JP. Thrombotic thrombocytopenic purpura and HTV infection. S Med J 88: 82-86, 1995.
21. Chulay JD, Bell AR. Long-term safety of valaciclovir for suppression of herpes simplex virus infections. Clin Infect Dis 23: 879, 1996.
22. Cotte L, Preckel MP, Cahen R, Dijoud F, Loire R, Chassard D, Trepo C. Fatal haemolytic uraemic syndrome in an AIDS patient. Eur J Med 1: 378-79, 1992.
23. Cruccu V, Parisio E, Pedretti D, Villa A, Confalonieri F. HTV-related thrombotic thrombocytopenic purpura (TTP) as first clinical manifestation of infection. Haematologica 79: 277-79, 1994.
24. del Arco A, Martinez MA, Pena JM, Gamallo C, Gonzalez JJ, Barbado FJ, Vazquez JJ. Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus infection: Demonstration of p24 antigen in endothelial cells. Clin Infect Dis 17: 360-63, 1993.
25. Doco-Lecompte T, Molina JM, Leleu-Nahmias G, Modai J. Thrombotic thrombocytopenic purpura in HIV infection. 3 cases. Presse Med 20: 1159-62, 1991.
26. Esforzado N, Poch E, Almirall J, Lopez-Pedret J, Revert L. Hemolytic uremic syndrome associated with HTV infection. AIDS 5: 1041-42, 1991.
27. Farina C, Gavazzeni G, Caprioli A, Remuzzi G. Hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infection in acquired immunodeficiency syndrome. Blood 75: 2465, 1990.
28. Feinberg J, Cooper D, Hurwitz S. Phase III international study of valaciclovir (VACV) for cytomegalovirus (CMV) prophylaxis in patients with advanced HTV disease. In: 11th International Conference on AIDS, 7-12 July 1996, Vancouver, 1996.
29. Francois A, Dhib M, Dubois D, Fillastre JP, Hemet J. Thrombotic microangiopathy (TMA) as the first manifestation of HIV infection. Clin Nephrol 39: 352-54, 1993.
30. Frem GJ, Rennke HG, Sayegh MH. Late renal allograft failure secondary to thrombotic microangiopathy-human immunodeficiency virus nephropathy. J Am Soc Nephrol 4: 1643-48, 1994.
31. Gervasoni C, Ridolfo AL, Bini T, Santambrogio S, Lupo A, Bertoli S, Galli M. Thrombotic thrombocytopenic purpura and hemolytic-uraemic syndrome in HPV-infected patients. In: 11th International Conference on AIDS, 7-12 July 1996, Vancouver, 1996.
32. Gore I. Disseminated arteriolar and capillary platelet thrombosis: A morphological study of its histogenesis. Am J Pathol 26: 155-75, 1950.
33. Jokela J, Flynn T, Henry K. Thrombotic thrombocytopenic purpura in a human immunodeficiency virus (HIV)-seropositive homosexual man. Am J Hematol 25: 341-43, 1987.
34. Jorda M, Rodriguez MM, Reik RA. Thrombotic thrombocytopenic purpura as the cause of death in an HTV-positive child. Pediatr Pathol 14: 919-25, 1994.
35. Kaloterakis A, Filiotou A, Kolnagou J, Procopiou C, Karvoutzis G. Thrombotic thrombocytopenic purpura in a woman with AIDS related complex: Complete remission with zidovudine. In: 7th International Conference on AIDS/3rd STD World Congress, 19-24 July 1992, Amsterdam, 1992.
36. Kaplan BS. Thrombotic microgangiopathy: A proposal for a new terminology for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. J Nephrol 8: 3-4, 1995.
37. Katznelson S, Wilkinson A, Rosenthal TR, Cohen A, Nast C, Danovitch GM. Cyclosporine-induced hemolytic uremic syndrome: Factors that obscure its diagnosis. Transplant Proc 26: 2608-9, 1994.
38. Kelleher P, Severn A, Tomson C, Lucas S, Parkin J, Pinching A, Miller R. The haemolytic uremic syndrome in patients with AIDS. Genitourin Med 72: 172-75, 1996.
39. Khuong M, De Truchis P, Oksenhendler E, Matheron S, Dosquet P, Clauvel JP. Thrombotic microangiopathy and HTV infection. In: 5th International Conference on AIDS, 4-9 June 1989, 1989.
40. Kiprov DD, Kwiatkowska BJ, Miller RG. Therapeutic apheresis in human immunodeficiency virus-related syndromes, In: Nydegger UE, ed. Therapeutic hemapheresis in the 1990s. Vol. 57. Basel: Karger, pp 184-97, 1990.
41. Leaf AN, Laubenstein LJ, Raphael B, Hochster H, Baez L, Karpatkin S. Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 (HIV-1) infection. Ann Intern Med 109: 194-97, 1988.
42. Manner CE, Gathe JJ, Novak I, Sawyer G, Holder P, Stool E. Thrombotic thrombocytopenic purpura (TTP) in a man with AIDS and prior idiopathic thrombocytopenic purpura (ITP). In: 9th International Conference on AIDS/4th STD World Congress, 6-11 June 1993, Berlin, 1993.
43. Maslo C, Peraldi MN, Desenclos JC, Sraer JD, Rozenbaum W. Evidence for the role of cytomegalovirus in thrombotic microangiopathy in HIV-infected patients. In: 2nd National Conference on Human Retroviruses, 29 Jan-2 Feb 1995, Washington, DC, 1995.
44. Mayo J, Collazos J, Martinez J. Thrombotic microangiopathy related to infection in an HIV-positive patient. Eur J Clin Microbiol Infect Dis 15: 254-56, 1996.
45. Medou JA, Hilpert F, Toledano D, Fouet P. Thrombotic microangiopathy and Listeria monocytogenes septicemia disclosing human immunodeficiency virus infection. Ann Med Interne 145: 503-4, 1994.
46. Meisenberg BR, Robinson WL, Mosley CA, Duke MS, Rabetoy GM, Kosty MP. Thrombotic thrombocytopenic purpura in human immunodeficiency (HIV)-seropositive males. Am J Hematol 27: 212-15, 1988.
47. Meyers JD, Reed EC, Shepp DH, Thornquist M, Dandliker PS, Vicary CA, Flournoy N, Kirk LE, Kersey JH, Thomas ED, Balfour HH, Jr. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med 318: 70-75, 1988.
48. Mittelman A, Bertram J, Henry DH, Snyder HW Jr, Messerschmidt GL, Ciavarella D, Ainsworth S, Kiprov D, Arlin Z. Treatment of patients with HIV thrombocytopenia and hemolytic uremic syndrome with protein A (Prosorba column) immunoadsorption. Sem Hematol 26(2 Suppl 1): 15-18, 1989.
49. Moschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaries: A hitherto undescribed disease. Proc NY Pathol Soc 24:21-24, 1924.
50. Nair JM, Bellevue R, Bertoni M, Dosik H. Thrombotic thrombocytopenic purpura in patients with the acquired immunodeficiency syndrome (AIDS)-related complex. A report of two cases. Ann Intern Med 109: 209-12, 1988.
51. Neild GH. Haemolytic-uraemic syndrome in practice. Lancet 343: 398-401, 1994.
52. Ninin E, Merrien D, Hamidou M, Testa A, Milpied B, Raffi F. Thrombotic microangiopathy in HTV infection - report of 4 cases. Rev Med Interne 17: 238-42, 1996.
53. Nosari AM, Landonio G, Caggese L, Cattaneo D, Muti G, Volonterio A. Thrombotic thrombocytopenic purpura associated with HIV infection: Report of two cases. Haematologica 79: 280-82, 1994.
54. Pachon J, Viciana P, Espigado I, Fernandez-Alonzo J. Thrombotic thrombocytopenic purpura in a patient with the acquired immunodeficiency syndrome. Rev Clin Esp 187: 41-42, 1990.
55. Peraldi MN, Maslo C, Desenclos JC, Raynal N, Rozenbaum W. Association between cytomagalovirus (CMV) infection and thrombotic microangiopathy (TMA) in HIV infected patients. J Am Soc Nephrol 6: 473, 1995.
56. Plantanias LC, Paiusco D, Bernstein S, Murali MR. Thrombotic thrombocytopenic purpura as the first manifestation of human immunodeficiency virus infection. Am J Med 87: 699-700, 1989.
57. Prentice HG, Gluckman E, Powles RL, Ljungman P, Milpied N, Fernandez Ranada JM, Mandelli F, Kho P, Kennedy L, Bell AR. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group. Lancet 343: 749-53, 1994.
58. Rao TK, Friedman EA, Nicastri AD. The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 316: 1062-68, 1987.
59. Rarick MU, Espina B, Mocharnuk R, Trilling Y, Levine AM. Thrombotic thrombocytopenic purpura in patients with human immunodeficiency virus infection: A report of three cases and review of the literature. Am J Hematol 40: 103-9, 1992.
60. Remuzzi G. HUS and TTP: Variable expression of a single entity. Kidney Int 32: 292-308, 1987.
61. Remuzzi G, Ruggenenti P. The hemolytic uremic syndrome. Kidney Int 48: 2-19, 1995.
62. Ridolfi RL, Bell WR. Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature. Medicine (Baltimore) 60: 413-28, 1981.
63. Ripamonti D, Gregis G, Casari S, Suardi MG, Chitoni M, Gregorini G, Rossi G, Giampiero C. Prevalence of thrombotic microangiopathy in a cohort of HIV infected patients. In: 11th International Conference on AIDS, 7-12 July 1996, Vancouver, 1996.
64. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 325: 393-97, 1991.
65. Rodon P, Blanchet S, Levallois D, Friocourt P. Thrombotic thrombocytopenic purpura following idiopathic thrombocytopenia in a man with AIDS. In: 4th European Conference on Clinical Aspects of Treatment of HIV Infection, 16-18 March 1994, Milan, 1994.
66. Routy JP, Beaulieu R, Monte M, Saint-Louis J, Sauvageau G, Toma E. Immunologic thrombocytopenia followed by thrombotic thrombocytopenic purpura in two HIV1 patients. Am J Hematol 38: 327-28, 1991.
67. Salem G, Terebelo H, Raman S. Human immunodeficiency virus associated with thrombotic thrombocytopenic purpura: Successful treatment with zidovudine. S Med J 84: 493-95, 1991.
68. Sarode R, McFarland JG, Flomenberg N, Casper JT, Cohen EP, Drobyski WR, Ash RC, Horowitz MM, Camilla B, Lawton C, Garbrecht F, Gottschall JL. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant 16: 271-75, 1995.
69. Segal GH, Tubbs RR, Ratliff NB, Miller ML, Longworth DL. Thrombotic thrombocytopenic purpura in a patient with AIDS. Cleve Clin J Med 57: 360-66, 1990.
70. Shivaram U, Cash M. Purpura fulminans, metastatic endophthalmitis, and thrombotic thrombocytopenic purpura ta an HIV-infected patient. NY State J Med 92: 313-14, 1992.
71. Taff ML, Schwartz IS, Churg J, Boglioli LR. Sudden death due to thrombotic thrombocytopenic purpura and HIV infection. Am J Forensic Med Pathol 12: 89-90, 1991.
72. Thompson CE, Damon LE, Ries CA, Linker CA. Thrombotic microangiopathies in the 1980s: Clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood 80: 1890-95, 1992.
73. Ucar A, Fernandez HF, Byrnes JJ, Lian EC, Harrington WJ Jr. Thrombotic microangiopathy and retroviral infections: A 13-year experience. Am J Hematol 45: 304-9, 1994.
74. Veenstra J, van der Lelie J, Mulder JW, Reiss P. Low-grade thrombotic thrombocytopenic purpura associated with HTV-1 infection. Br J Haematol 83: 346-47, 1993.
75. Weller S, Blum MR, Doucette M, Burnette T, Cederberg DM, de Miranda P, Smiley ML. Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers. Clin Pharmacol Ther 54: 595-605, 1993.
76. Yospur LS, Sun NC, Figueroa P, Niihara Y. Concurrent thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an HIV-positive patient: Case report and review of the literature. Am J Hematol 51: 73-78, 1996.